Diabetic Medicine · 1996 · 25 citations · 0 references
MedicineEndocrinologyDiabetologyMetabolic RegulationMetabolic StabilityBlood Glucose MonitoringDiabetes MellitusGlucose HomeostasisGlycemic ControlGlycemic MonitoringInsulin ResistanceFasting GlycemiaGlucose Metabolism BiomarkersGlucose MonitoringGlucose Tolerance Impairment DetectionImpaired Glucose ToleranceImpaired Insulin SensitivityLaboratory Plasma Glucose TestingProinsulin Processing
To evaluate the clinical significance of proinsulin determination, we measured glucose, insulin, C-peptide and proinsulin during 75-g oral glucose loading in 59 patients. In a 2.5-year follow-up study of 37 subjects with impaired glucose tolerance (IGT) at the initial test, 11 patients changed from IGT to a normal state and 5 patients showed worsening to overt Type 2 diabetes with elevation of fasting plasma glucose; 21 patients remained unchanged. Although our data showed that both fasting (IGT: p = 0.4523) and 120-min plasma glucose (IGT: p = 0.8168) values at the initial test were not significantly correlated with increased fasting plasma glucose levels in a 2.5-year follow-up study, subjects with a higher 120-min proinsulin response to glucose during the initial OGTT showed a significant correlation (IGT: p < 0.0001) with increased fasting plasma glucose levels after follow-up period and developed Type 2 diabetes. The present findings suggest that the proinsulin response to glucose loading might be a useful indicator for predicting worsening to diabetes in subjects with impaired glucose tolerance.